Scholars Central

Research articlePublished 30 Sep 2014

Dual release tablet: Clinical outcome and evaluation

Authors: C. Rubina Reichal, N. Thirumoorthy, M. Gopal Rao

Journal of Chemical and Pharmaceutical Research

Volume 6 · Issue 9 · Pages 219–229

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The goal in designing the bilayer tablets are suitable for the sequential release of two drugs in which one layer is immediate release as loading dose and second layer as maintenance dose. The Fixed Dose Combination (FDC) of two or more drugs in single dosage form, which is more safe and effective for single or different diseases. The bimodal release of formulation is mainly used to achieve rapid and extended release in a single dosage form. For good quality bilayer tablet, the machinery should be constructed as per GMP. The present study focuses the dual release tablets on different types of press, technology and the therapeutic benefits of bilayer tablets.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Chemical and Pharmaceutical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Chemical and Pharmaceutical Research
  • SubjectPharmaceutical Sciences
  • SubjectChemistry
  • BylineArticles whose byline prints “C. Rubina Reichal”
  • BylineArticles whose byline prints “N. Thirumoorthy”
  • BylineArticles whose byline prints “M. Gopal Rao”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels